Our research focus on elucidating the treatment avenues for refractory granulomatous mastitis. Leveraging an integrative approach that combines traditional Chinese and Western medicinal methodologies simultaneously will expose the complex pathogenic mechanisms driving the disease and its complications, with a focus to endeavor to alleviate these issues and improve patient prognostication. Our research reports an easier, time-saving, and the economical protocol for efficiently isolating and growing primary human mammary epithelial cells, or HMECs, from a small amount of mammary tissue.

This protocol is suitable for quickly producing primary HMECs for lab and clinical applications. Building upon this study, we aim to develop a granulomatous mastitis mammary epithelial cell model to deepen our understanding of etiology and validated treatment strategies.